- Home
- ENGN vs TSVT Comparison
ENGN vs TSVT Comparison
Compare ENGN & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- TSVT
- Stock Information
- Founded
- ENGN 1999
- TSVT 2021
- Country
- ENGN Canada
- TSVT United States
- Employees
- ENGN N/A
- TSVT N/A
- Industry
- ENGN
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ENGN
- TSVT Health Care
- Exchange
- ENGN Nasdaq
- TSVT Nasdaq
- Market Cap
- ENGN 297.7M
- TSVT 258.9M
- IPO Year
- ENGN N/A
- TSVT N/A
- Fundamental
- Price
- ENGN $2.96
- TSVT $4.99
- Analyst Decision
- ENGN Buy
- TSVT Buy
- Analyst Count
- ENGN 7
- TSVT 4
- Target Price
- ENGN $23.29
- TSVT $6.50
- AVG Volume (30 Days)
- ENGN 49.1K
- TSVT 726.2K
- Earning Date
- ENGN 06-13-2025
- TSVT 05-07-2025
- Dividend Yield
- ENGN N/A
- TSVT N/A
- EPS Growth
- ENGN N/A
- TSVT N/A
- EPS
- ENGN N/A
- TSVT N/A
- Revenue
- ENGN N/A
- TSVT $48,365,000.00
- Revenue This Year
- ENGN N/A
- TSVT $84.48
- Revenue Next Year
- ENGN N/A
- TSVT $9.69
- P/E Ratio
- ENGN N/A
- TSVT N/A
- Revenue Growth
- ENGN N/A
- TSVT N/A
- 52 Week Low
- ENGN $3.27
- TSVT $2.29
- 52 Week High
- ENGN $14.67
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- ENGN 21.28
- TSVT 71.10
- Support Level
- ENGN $3.51
- TSVT $4.97
- Resistance Level
- ENGN $3.99
- TSVT $4.99
- Average True Range (ATR)
- ENGN 0.41
- TSVT 0.01
- MACD
- ENGN -0.04
- TSVT -0.04
- Stochastic Oscillator
- ENGN 1.38
- TSVT 50.00
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.